Jefferies analyst Thomas Wei reiterated a Buy rating and $11 price target on Arena Pharma (NASDAQ: ARNA) following Belviq sales ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE